| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999773 | Urologic Oncology: Seminars and Original Investigations | 2015 | 6 Pages |
Abstract
For patients undergoing salvage RT after RP for a rising PSA level, the absence of PSA level decline during RT is predictive of biochemical and clinical failure and may be used to rapidly identify poor responders.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Pierre Blanchard, Moudar Bakkour, Renaud De Crevoisier, Antonin Levy, Hervé Baumert, Jean-Jacques Patard, Pierre Wibault, Karim Fizazi, Alberto Bossi,